Regalo Bakery: "Manju Blackbeans (Hopia Monggo)" [UPC#78253230917] packaged on a foam tray with six pieces each, wrapped in clear plasti...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0230-2017.
Regalo Bakery is recalling Manju Blackbeans (Hopia Monggo due to undeclared eggs, wheat, soy, and artificial food coloring (Red 40 & 3, Yellow 5 & 6).
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0230-2017.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Regalo's Favorite Of Hawaii Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0230-2017.
Regalo's Favorite of Hawaii Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Regalo's Favorite Of Hawaii Inc. Recall FAQ
Regalo's Favorite Of Hawaii Inc. is the subject of a food safety report: Regalo Bakery: "Manju Blackbeans (Hopia Monggo)" [UPC#78253230917] packaged on a foam tray with six pieces each, wrapped in clear plasti.... The notice was published on September 1, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 30 units are potentially affected.